Medicare Enrolled
Dr. Patrick Acevedo, M.D.
Medical Oncology · Ocala, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Acevedo from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Acevedo? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Acevedo
Dr. Patrick Acevedo is a medical oncology in Ocala, FL, with 20 years in practice. Based on federal Medicare data, Dr. Acevedo performed 185,470 Medicare services across 5,127 unique beneficiaries.
Between the years covered by Open Payments, Dr. Acevedo received a total of $16,336 from 96 pharmaceutical and/or device companies across 893 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Acevedo is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice▲ Top 13% volume in FL$ $16,336 industry payments
Medicare Practice Summary
Medicare Utilization ↗185,470
Medicare services
Top 13% in FL for medical oncology
5,127
Unique beneficiaries
$8
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~9,274 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) | 88,740 | $0 | $4 |
| Iron sucrose injection (Venofer) | 24,300 | $0 | $5 |
| Pembrolizumab injection (Keytruda) | 16,200 | $43 | $137 |
| Denosumab injection (Prolia/Xgeva) | 9,420 | $18 | $51 |
| Azacitidine chemotherapy injection | 8,400 | $0 | $4 |
| Anti-nausea injection (aprepitant) | 7,540 | $1 | $5 |
| Epoetin alfa injection (Procrit) for anemia | 6,520 | $6 | $23 |
| Immune globulin infusion (Gammagard) | 5,488 | $36 | $108 |
| Blood draw (venipuncture) | 3,125 | $8 | $9 |
| Complete blood count (CBC) with differential | 3,023 | $8 | $29 |
| Dexamethasone injection (steroid) | 2,471 | $0 | $3 |
| Office visit, established patient (20-29 min) | 1,707 | $64 | $239 |
| Anti-nausea injection (ondansetron/Zofran) | 1,424 | $0 | $9 |
| Drug injection, under skin or into muscle | 965 | $10 | $69 |
| Anti-nausea injection (Aloxi/palonosetron) | 800 | $1 | $28 |
| Injection of additional new drug or substance into vein | 592 | $12 | $61 |
| Administration of chemotherapy into vein, 1 hour or less | 571 | $96 | $378 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 507 | $1 | $6 |
| Office visit, established patient (30-39 min) | 452 | $95 | $339 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 370 | $47 | $189 |
| Administration of chemotherapy into vein, each additional hour | 234 | $21 | $79 |
| Injection, diphenhydramine hcl, up to 50 mg | 182 | $1 | $3 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 178 | $15 | $56 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 166 | $135 | $562 |
| Injection, carboplatin, 50 mg | 163 | $2 | $41 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 157 | $24 | $89 |
| Injection of drug or substance into vein | 151 | $27 | $156 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 146 | $21 | $84 |
| Injection, methylprednisolone sodium succinate, up to 40 mg | 121 | $3 | $11 |
| Administration of additional new drug or substance into vein, 1 hour or less | 120 | $48 | $178 |
| Injection, zoledronic acid, 1 mg | 101 | $7 | $69 |
| Prothrombin time test (blood clotting) | 92 | $4 | $15 |
| New patient office visit, complex (60-74 min) | 89 | $159 | $585 |
| Automated urinalysis | 81 | $2 | $8 |
| Infusion into a vein for hydration, each additional hour | 81 | $10 | $42 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 76 | $17 | $59 |
| Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session | 67 | $270 | $1,100 |
| CT guidance for radiation therapy | 65 | $57 | $300 |
| Infusion, normal saline solution , 1000 cc | 58 | $2 | $7 |
| Hospital follow-up visit, low complexity | 57 | $39 | $109 |
| Initial hospital admission, high complexity | 54 | $137 | $556 |
| Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 6-10 mev | 52 | $176 | $587 |
| Hospital follow-up visit, moderate complexity | 45 | $63 | $197 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 43 | $54 | $206 |
| Red blood count automated, with additional calculations | 38 | $5 | $20 |
| Infusion into a vein for hydration, 31-60 minutes | 37 | $25 | $156 |
| Stereoscopic x-ray guidance for localization of target volume for the delivery of radiation therapy | 30 | $41 | $145 |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 28 | $1 | $7 |
| Red blood count, automated test | 26 | $4 | $10 |
| Continuing radiation therapy consultation per week | 21 | $66 | $185 |
| Office visit, established patient, complex (40-54 min) | 19 | $135 | $474 |
| Initial hospital admission, moderate complexity | 19 | $98 | $377 |
| Drawing of blood for a medical problem | 16 | $55 | $277 |
| Biopsy and aspiration of bone marrow sample for diagnosis | 15 | $132 | $467 |
| Hospital follow-up visit, high complexity | 15 | $94 | $285 |
| Office visit, established patient (10-19 min) | 12 | $44 | $147 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
51.3% high complexity
43.7% medium
5.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$16,336
Total received (2018-2024)
Avg $2,334/year across 7 years
Top 31% in FL for medical oncology
96
Companies
893
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$15,894 (97.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$442 (2.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$2,517
2023$2,174
2022$2,040
2021$2,053
2020$3,017
2019$2,186
2018$2,350
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$1,859
Janssen Biotech, Inc.
$1,358
E.R. Squibb & Sons, L.L.C.
$839
PFIZER INC.
$783
Celgene Corporation
$740
Seagen Inc.
$737
Lilly USA, LLC
$658
AstraZeneca Pharmaceuticals LP
$603
Amgen Inc.
$590
Genentech USA, Inc.
$538
Incyte Corporation
$449
Astellas Pharma US Inc
$446
Merck Sharp & Dohme Corporation
$358
Pharmacyclics LLC, An AbbVie Company
$320
Eisai Inc.
$288
Foundation Medicine, Inc.
$275
Merck Sharp & Dohme LLC
$264
GENZYME CORPORATION
$246
Gilead Sciences, Inc.
$232
GlaxoSmithKline, LLC.
$230
Daiichi Sankyo Inc.
$211
Boehringer Ingelheim Pharmaceuticals, Inc.
$204
JAZZ PHARMACEUTICALS INC.
$186
Bayer HealthCare Pharmaceuticals Inc.
$183
Seattle Genetics, Inc.
$177
Clovis Oncology, Inc.
$174
AMAG Pharmaceuticals, Inc.
$159
Pharmacyclics LLC, an AbbVie Company
$131
BeiGene USA, Inc.
$122
Bayer Healthcare Pharmaceuticals Inc.
$118
Kite Pharma, Inc.
$116
MEDIVATION FIELD SOLUTIONS LLC
$115
Octapharma USA, Inc.
$114
Karyopharm Therapeutics Inc.
$111
EMD Serono, Inc.
$103
ABBVIE INC.
$98
Takeda Pharmaceuticals U.S.A., Inc.
$94
Exelixis Inc.
$90
Regeneron Healthcare Solutions, Inc.
$89
AbbVie, Inc.
$79
ARRAY BIOPHARMA INC
$75
Stemline Therapeutics Inc.
$75
Pharmacosmos Therapeutics Inc.
$71
Alexion Pharmaceuticals, Inc.
$68
EISAI INC.
$64
Agios Pharmaceuticals, Inc.
$58
Jazz Pharmaceuticals Inc.
$55
Heron Therapeutics, Inc.
$55
Sun Pharmaceutical Industries Inc.
$54
TAIHO ONCOLOGY, INC.
$54
SOBI, INC
$52
AbbVie Inc.
$50
Rigel Pharmaceuticals, Inc.
$48
TESARO, Inc.
$47
Tempus AI, Inc
$44
Aurobindo Pharma USA, Inc.
$40
Myriad Genetic Laboratories, Inc.
$40
Puma Biotechnology, Inc.
$38
Lexicon Pharmaceuticals, Inc.
$38
PharmaEssentia USA Corporation
$38
G1 Therapeutics, Inc.
$35
Ipsen Biopharmaceuticals, Inc
$34
TG THERAPEUTICS, INC.
$33
Emmaus Medical, Inc.
$32
Secura Bio, Inc.
$32
MorphoSys, US Inc.
$31
Dendreon Pharmaceuticals LLC
$29
Medtronic, Inc.
$28
Kyowa Kirin, Inc.
$27
Dova Pharmaceuticals
$27
SERVIER PHARMACEUTICALS LLC
$26
Global Blood Therapeutics, Inc.
$25
PUMA BIOTECHNOLOGY, INC.
$25
Servier Pharmaceuticals LLC
$24
Mirati Therapeutics, Inc.
$24
Sumitomo Pharma America, Inc.
$23
Aveo Pharmaceuticals, Inc.
$23
Blueprint Medicines Corporation
$23
Telix Pharmaceuticals
$23
Teva Pharmaceuticals USA, Inc.
$22
Deciphera Pharmaceuticals Inc.
$22
SECURA BIO, INC.
$21
Spectrum Pharmaceuticals Inc.
$20
EUSA Pharma (US) LLC
$20
TerSera Therapeutics LLC
$19
Smith+Nephew, Inc.
$19
AVEO Pharmaceuticals, Inc.
$17
Novocure Inc.
$17
Otsuka America Pharmaceutical, Inc.
$17
Epizyme, Inc.,
$15
Sirtex Medical Inc
$13
Tactile Systems Technology Inc
$13
NanoString Technologies, Inc.
$12
Array BioPharma Inc.
$12
Janssen Pharmaceuticals, Inc
$5
Veracyte, Inc.
$1
Top 3 companies account for 24.8% of total payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · ALIMTA · ALUNBRIG · AUGTYRO · AYVAKIT · Alecensa · Aliqopa · Avastin · BENDEKA · BESREMI · BLENREP · BOSULIF · BRACANALYSIS CDX · BRAFTOVI · BRUKINSA · Balversa · Bavencio · Blincyto · Braftovi · CABOMETYX · CALQUENCE · CERDELGA · CEREZYME · CINVANTI · COPIKTRA · COSELA · CYRAMZA · Cabometyx · DARZALEX · Doptelet · ELITEK · ELREXFIO · ELZONRIS · ENHERTU · EPKINLY · ERLEADA · Endari · Enhertu · Erleada · FARYDAK · FERAHEME · FOTIVDA · FOUNDATIONONE · FRUZAQLA · Fabhalta · Farydak · Flexitouch Plus · Folotyn · GAUCHER-DISEASE · GAZYVA · GILOTRIF · Gazyva · Halaven · IBRANCE · ICLUSIG · ILLUCCIX · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INREBIC · Imbruvica · JAKAFI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · MEKINIST · MONJUVI · MONOFERRIC · NERLYNX · Nerlynx · Neulasta · Nplate · Nubeqa · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ODOMZO · ODOMZO (sonidegib) capsules · OJJAARA · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · OSTEOCOOL RF ABLATION SYSTEM · OXBRYTA · Onivyde · Optune Lua (NovoTTF-200T) · Orserdu · PADCEV · PLUVICTO · PROMACTA · PROSIGNA ASSAY · PROVENGE · PYRUKYND · Padcev · Perjeta · Phesgo · Polivy · Pomalyst · Prolia · QINLOCK · REBLOZYL · REMICADE · RETEVMO · RYBREVANT · RYDAPT · Revlimid · Rezlidhia · Rubraca · SANCUSO · SANDOSTATIN · SARCLISA · SCEMBLIX · SIR-Spheres Microspheres · SOLIRIS · SPRYCEL · SUSTOL · SUTENT · Santyl · Somatuline Depot · Stivarga · Sylvant · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TEVIMBRA · TIBSOVO · TIVDAK · TUKYSA · Tavalisse · Tibsovo · Trodelvy · UKONIQ · ULTOMIRIS · Ultomiris · VENCLEXTA · VERZENIO · VONJO · VOTRIENT · VYNDAQEL · VYXEOS · Vanflyta · Vectibix · Venclexta · Vitrakvi · XALKORI · XARELTO · XGEVA · XOSPATA · XPOVIO · XT CDX · XTANDI · Xermelo · Xofigo · Xospata · ZEJULA · ZEPZELCA · ZYTIGA · Zevalin · Zoladex · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $9 per 100 Medicare services performed
Geographic Context
Medical Oncologys within 10 mi
8
Per 100K population
2.1
County median income
$58,535
Nearest hospital
MARION COMMUNTIY HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Acevedo is a mixed practice specialist, with above-average Medicare volume (top 13% in FL), and low-engagement industry engagement, with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Acevedo experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Acevedo performed 88,740 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Acevedo receive payments from pharmaceutical companies?
Yes. Dr. Acevedo received a total of $16,336 from 96 companies across 893 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Acevedo's costs compare to other medical oncologys in Ocala?
Dr. Acevedo's average Medicare payment per service is $8. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Acevedo) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Medical Oncologys in Ocala
Browse medical oncologys in Ocala ranked by procedure volume and transparency data.
Highest volume
Top Medical Oncologys in FL
Medical Oncologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Oncologys in FL
Which FL medical oncologys receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc..
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology